| Value | ₹0.89 Cr |
|---|
NSE filing, NSE: ZIMLAB. Summary written from the filing by ALFA Finder's alert engine.
Zim Laboratories Ltd: key numbers
- Share price
- ₹134.00
- Market cap
- ₹719.0 Cr
- Revenue (annual)
- ₹374.4 Cr
- Net profit (annual)
- ₹5.84 Cr
- P/E (TTM)
- 194.5×Sector 46.1×
- Promoter holding
- 30.30%-0.06% QoQ
- FII holding
- 0.17%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Zim Laboratories Ltd
All →Zim Laboratories Board Meeting Date
Zim Laboratories has scheduled a board meeting on 4 November 2026 to consider its unaudited quarterly results for the quarter ended 30 September 2026. The trading window stays closed from 1 October to 6 November 2026.
Zim Laboratories Regulatory Approval
Zim Laboratories received TGA GMP certification from Australia's Therapeutic Goods Administration for its Nagpur manufacturing facility. The certification covers various dosage forms and is valid until June 2028.
- From
- Therapeutic Goods Administration (TGA), Australia
Zim Laboratories Credit Rating
CARE Ratings has reaffirmed the credit ratings of Zim Laboratories Limited for its bank facilities, revising the outlook on long-term facilities to negative.
Zim Laboratories Other Announcement
Zim Laboratories Limited filed a certificate confirming compliance with Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended 30th September 2026.
Zim Laboratories Merger & Restructuring Worth ₹1,404,640 Cr
ZIM Laboratories completed incorporation of its wholly-owned Chilean subsidiary, ZIM Laboratories SpA. The LATAM expansion entity is now operational, marking completion of the February 2026 board-approved plan.
- Value
- ₹14,04,640 Cr
Zim Laboratories Merger & Restructuring
ZIM Laboratories Limited incorporated a wholly owned subsidiary, 'ZIM Laboratories SpA', in Chile. This expansion aims to develop its pharmaceutical business in the LATAM region.
Other merger & restructuring announcements
All →Robokidz Eduventures Merger & Restructuring Worth ₹0.18 Cr
Robokidz Eduventures will transfer its YEA Mundhwa Activity Centre to wholly owned subsidiary Robokidz Retail for ₹0.18 Crore. The restructuring consolidates activity-centre operations under the subsidiary.
- Value
- ₹0.18 Cr
Yogi Merger & Restructuring
Yogi Horizons LLP and Yogi Realtors LLP, subsidiaries of Yogi Limited, executed restated LLP agreements inducting new partners. Yogi's profit share falls to 43% and 76% respectively.
Astra Microwave Products Merger & Restructuring
Astra Microwave received exchange observation letters for its Space business demerger into Astra Space Technologies. The scheme remains subject to regulatory approvals.
Praj Industries Merger & Restructuring Worth ₹100 Cr
Praj Industries' board approved in-principle investment of up to ₹100 crore in a joint venture with BPCL. The JV will set up compressed biogas plants across India.
- Value
- ₹100.0 Cr
Dollex Agrotech Merger & Restructuring Worth ₹0.01 Cr
DOLLEX AGROTECH LIMITED will hold a 99.99% stake in newly incorporated wholly owned subsidiary Dollex Green Ventures Private Limited via cash subscription. The entity targets renewable energy, biogas and bio-fertilizers.
- Value
- ₹0.01 Cr
Dollex Agrotech Merger & Restructuring
Dollex Agrotech incorporated wholly owned subsidiary Dollex Green Ventures on 28 Oct 2026. It will pursue biogas, Bio-CNG and renewable energy; no investment amount is disclosed.